Ondine Biomedical Inc. (LON:OBI – Get Free Report) traded down 2% on Tuesday . The company traded as low as GBX 8.58 ($0.11) and last traded at GBX 8.62 ($0.11). 158,609 shares traded hands during mid-day trading, a decline of 6% from the average session volume of 168,652 shares. The stock had previously closed at GBX 8.80 ($0.11).
Ondine Biomedical Price Performance
The firm has a 50-day moving average of GBX 8.28 and a 200-day moving average of GBX 7.63. The stock has a market cap of £23.90 million, a PE ratio of -287.33 and a beta of 0.10. The company has a debt-to-equity ratio of 1,847.37, a current ratio of 0.80 and a quick ratio of 8.26.
About Ondine Biomedical
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
Featured Articles
- Five stocks we like better than Ondine Biomedical
- What Investors Need to Know About Upcoming IPOs
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- Comparing and Trading High PE Ratio Stocks
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Breakout Stocks: What They Are and How to Identify Them
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
